Table 1 Baseline characteristics of patients among different mean LDL-C groups
Parameter | LDL-C <70 mg/dl (N = 206, 24% ) | LDL-C 70–100 mg/dl (N = 405, 46%) | LDL-C >100 mg/dl (N = 257, 30%) | P-value |
|---|---|---|---|---|
Age (years) | 66.0 ± 11.2 | 63.3 ± 11.0 | 60.7 ± 11.1 | <0.001 |
Male | 65.6% | 62.2% | 58.7% | 0.312 |
Body mass index (kg/m2) | 22.5 ± 4.4 | 22.8 ± 4.5 | 23.5 ± 5.2 | 0.122 |
LVEF (%) | 50.0 ± 13.8 | 50.1 ± 13.8 | 50.9 ± 14.0 | 0.772 |
Creatinine (mg/dl) | 2.2 ± 10.2 | 1.6 ± 2.2 | 1.7 ± 7.6 | 0.492 |
Hemoglobin (g/dl) | 12.5 ± 2.8 | 12.4 ± 2.1 | 12.7 ± 2.0 | 0.224 |
Baseline LDL-C (mg/dl) | 97.3 ± 38.5 | 111.2 ± 39.0 | 135.3 ± 44.0 | <0.001 |
Baseline non-HDL-C (mg/dl) | 121.9 ± 39.5 | 137.5 ± 43.9 | 162.7 ± 48.6 | <0.001 |
Baseline HDL-C (mg/dl) | 40.4 ± 11.3 | 39.2 ± 11.6 | 40.4 ± 9.6 | 0.322 |
Smoking | 38.0% | 35.6% | 37.4% | 0.714 |
Hypertension | 61.2% | 57.3% | 53.3% | 0.222 |
Dyslipidemia | 29.6% | 30.4% | 38.1% | 0.978 |
Diabetes mellitus | 30.1% | 27.4% | 24.1% | 0.348 |
Chronic kidney disease | 9.7% | 7.9% | 3.9% | 0.039 |
History of CAD | 10.2% | 8.9% | 12/1% | 0.419 |
History of stroke | 4.9% | 4.2% | 4.7% | 0.921 |
STEMI | 78.0% | 80.0% | 73.7% | 0.190 |
Statin | 92.2% | 93.8% | 92.2% | 0.65 |
Ezetimibe | 2.4% | 2.5% | 7.4% | 0.003 |